December 1, 2014EuroIntervention
Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry
Key result
Emergent cardiac surgery during TAVI occurred in 1.2% of patients (similar between transapical and transfemoral approaches) and was associated with a high 30-day mortality of 51.9%.
Population
2,307 patients undergoing transcatheter aortic valve implantation prospectively enrolled in the multicentre…
Design
Cohort
Follow-up
30 days
Authors
Discussion
Loading...
Member takes
Implication
High mortality after emergent surgery during TAVI warrants complication prevention focus; leaves open prospective trials on mitigation strategies.
Study Design
Type
Observational (n=2,307)
Multicenter
Yes
Structured PICO
P
Population
2,307 patients undergoing transcatheter aortic valve implantation (TAVI) prospectively enrolled in the multicentre Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry
I
Intervention
Transcatheter aortic valve implantation (TAVI)
O
Outcome
Incidence, reasons, and 30-day mortality of emergent cardiac surgery (ECS) during TAVIhard clinical
Emergent cardiac surgery during TAVI is rare (1.2%) but associated with very high 30-day mortality (52%), highlighting the critical importance of complication prevention.
Cite This Study
Eggebrecht et al. (2014) conducted an observational in Transcatheter aortic valve implantation (TAVI) (n=2,307). Transcatheter aortic valve implantation (TAVI) was evaluated on Requirement for emergent cardiac surgery (ECS). Emergent cardiac surgery during TAVI occurred in 1.2% of patients (similar between transapical and transfemoral approaches) and was associated with a high 30-day mortality of 51.9%.